Aug. 20, 2011
/PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "Company"), a leading
-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on
, 2011 at
time, at our executive office, 15/A-D, Huaxin International Tower, No. 219, Qingnian Ave., Shenhe District,
People's Republic of China
. The shareholder record date is
August 15, 2011
3SBio has filed its annual report on Form 20-F with the audited financial statements for the fiscal year ended
, 20010, with the U.S. Securities and Exchange Commission (the "SEC"). 3SBio's annual report on Form 20-F can be accessed on the Investors section of the Company's website at
, as well as on the SEC's website at
The materials related to the annual general meeting, including the notice of meeting, the proxy statement, and the voting card may also be accessed and downloaded at the Investors section of the Company website.
Shareholders may request a hard copy of the above documents free of charge by contacting
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in
. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in
, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
for more information.
Chief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
Director of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.